Category Archives: (Sandbox Syndication Account) Health News (Master Feed)
Germany’s Stada has spun off Russian business – newspaper
BERLIN (Reuters) - Generic drugmaker Stada has spun off its Russian business into a separate company called Nizhpharm, the Welt am Sonntag newspaper reported on Saturday, citing a spokesperson from th...
Dec 22, 2023
CDC says JN.1 variant accounts for 39%-50% of COVID cases in US
(Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) said on Friday that COVID subvariant JN.1 accounts for 39% to 50% of cases in the United States as of Dec. 23, according to the ag...
Dec 22, 2023
GSK to cut US prices for Advair, Valtrex and Lamictal
(Reuters) - Drugmaker GSK Plc said on Friday that it will cut U.S. list prices on asthma drug Advair, herpes drug Valtrex, and anti-epileptic medication Lamictal on Jan. 1, 2024. The price cuts come a...
Dec 22, 2023
UnitedHealth agrees to sell Brazil unit Amil -report
SAO PAULO (Reuters) - The board of UnitedHealth Group approved the sale of its Brazilian health insurance operator Amil to businessman Jose Serpieri Filho, local newspaper Valor Economico said on Frid...
Dec 22, 2023
Cuba quietly authorizes euthanasia
By Marc Frank and Nelson Acosta HAVANA (Reuters) - Cuba on Friday became the second country in Latin America and the Caribbean to authorize euthanasia, following Colombia. The Communist-run country's ...
Dec 22, 2023
US finds no novel pathogens in genetic testing of mystery illness in dogs
(Reuters) - Testing of the mysterious respiratory illness affecting dogs across the United States has not yet revealed any new pathogens or any common cause for the wave of infections that have alarme...
Dec 22, 2023
Bristol Myers to buy Karuna Therapeutics for $14 billion
(Reuters) -Bristol Myers Squib agreed to buy Karuna Therapeutics for $14 billion on Friday, gaining a promising experimental schizophrenia drug that would help the drugmaker against patent expiration ...
Dec 22, 2023
Exclusive-India probe into bribery claim in toxic syrup tests nears completion
By Krishna N. Das NEW DELHI (Reuters) - India is close to finishing an investigation into a "comprehensive and exhaustive" complaint that a state drug regulator, in return for a bribe, helped switch s...
Dec 21, 2023
US FDA approves Ionis-AstraZeneca’s nerve disease drug
By Mariam Sunny and Puyaan Singh (Reuters) - The U.S. Food and Drug Administration (FDA) on Thursday approved Ionis Pharmaceuticals and partner AstraZeneca's drug to treat nerve damage caused by a lif...
Dec 21, 2023
US FDA warns about counterfeit versions of Novo’s diabetes drug Ozempic
(Reuters) - The U.S. Food and Drug Administration on Thursday warned consumers not to use counterfeit versions of Novo Nordisk's diabetes drug Ozempic that have been found in the country's drug supply...
Dec 21, 2023
